Vladimir N Chouljenko
Overview
Explore the profile of Vladimir N Chouljenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nabi R, Chouljenko V, Musarrat F, Davis M, Mohan H, Ghavimi R, et al.
J Med Virol
. 2025 Feb;
97(2):e70220.
PMID: 39930884
Oncolytic virotherapy (OVT) aims to disrupt the tumor microenvironment and provide a unique therapeutic approach against solid tumors. Herpes simplex virus type-1 (HSV-1) has shown strong promise for treating various...
2.
Chouljenko A, Stanfield B, Melnyk T, Dutta O, Chouljenko V
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684396
This study focuses on the common presence of repetitive sequences within the sturgeon genome that may contribute to enhanced immune responses against infectious diseases. A repetitive 675 bp VAC-2M sequence...
3.
Saade D, Liu C, Mills E, Stanfield B, Thieulent C, Chouljenko V, et al.
Vet Ophthalmol
. 2024 Oct;
PMID: 39379194
Objective: To determine the replication kinetics and cytopathic effect (CPE) of feline calicivirus (FCV) in feline corneal epithelial cells (FCEC). Animals Studied: Seven archived FCV isolates and one archived feline...
4.
Stanfield B, Ruiz E, Chouljenko V, Kousoulas K
Virus Genes
. 2024 Feb;
60(2):148-158.
PMID: 38340271
Guinea Pig Herpes-Like Virus (GPHLV) is a virus isolated from leukemic guinea pigs with herpes virus-like morphology described by Hsiung and Kaplow in 1969. GPHLV transformed embryonic cells from Syrian...
5.
Nabi R, Musarrat F, Menk P Lima J, Langohr I, Chouljenko V, Kousoulas K
Front Mol Biosci
. 2023 Jun;
10:1199068.
PMID: 37388243
Oncolytic viruses (OVs) provide new modalities for cancer therapy either alone or in combination with synergistic immunotherapies and/or chemotherapeutics. Engineered Herpes Simplex Virus Type-1 (HSV-1) has shown strong promise for...
6.
Stanfield B, Bravo F, Dixon D, Chouljenko V, Kousoulas K, Bernstein D
Vaccine
. 2022 Sep;
40(42):6093-6099.
PMID: 36114130
Herpes simplex virus type 1 and 2 (HSV-1 and HSV-2 respectively) cause life-long latent infections resulting in recurrent orofacial and genital blisters or sores. Ensued disease can be painful and...
7.
Nabi R, Lewin A, Collantes T, Chouljenko V, Kousoulas K
Front Immunol
. 2021 Dec;
12:789454.
PMID: 34868077
Herpes simplex virus type-1 (HSV-1) ocular infection is one of the leading causes of infectious blindness in developed countries. The resultant herpetic keratitis (HK) is caused by an exacerbated reaction...
8.
Jambunathan N, Clark C, Musarrat F, Chouljenko V, Rudd J, Kousoulas K
Viruses
. 2021 Sep;
13(9).
PMID: 34578430
Herpes simplex virus type-1 (HSV-1) and type-2 (HSV-2) are prototypical alphaherpesviruses that are characterized by their unique properties to infect trigeminal and dorsal root ganglionic neurons, respectively, and establish life-long...
9.
Naidu S, Nabi R, Cheemarla N, Stanfield B, Rider P, Jambunathan N, et al.
PLoS One
. 2020 Feb;
15(2):e0228252.
PMID: 32027675
Herpes simplex virus type-1 (HSV-1) can cause severe ocular infection and blindness. We have previously shown that the HSV-1 VC2 vaccine strain is protective in mice and guinea pigs against...
10.
Caskey J, Hasenkampf N, Martin D, Chouljenko V, Subramanian R, Cheslock M, et al.
Front Microbiol
. 2019 May;
10:690.
PMID: 31057493
Recent studies have shown that can form antibiotic-tolerant persisters in the presence of microbiostatic drugs such as doxycycline. Precisely how this occurs is yet unknown. Our goal was to examine...